WALTHAM, Mass., Sept. 9, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that it will present at the Rodman & Renshaw 13th Annual Healthcare Conference on Tuesday, September 13, 2011 at 9:10 a.m. Eastern Time. Pieter Muntendam, MD, President and CEO of the Company, will present an overview of BG Medicine and highlights of recently concluded studies on galectin-3 and cardiac disease. The Company's presentation will be available to the public through a webcast accessible by visiting: http://www.wsw.com/webcast/rrshq20/bgmd/ or the "Investors" section of the Company's website at www.bg-medicine.com. Replays will be available for 30 days after the presentation.
